Serum, dried blood spot and urine steroid profiles in trained females: impact of oral contraception and consequences for the athlete biological passport
Introduction The objective of this study was to explore in young female athletes, with normal menstrual cycle (NMC) or using combined oral contraceptives (COC) (low ethinylestradiol/levonorgestrel), the impact of the hormonal status on the serum, dried blood spot (DBS) and urine steroid profiles of the Athlete Biological Passport (ABP) simultaneously. Method We therefore examined in 15 COC female athletes during active hormone intake and washout phase compared to 20 NMC female athletes in early follicular, end follicular and mid-luteal phases, 6 urinary steroidal markers and their relative ratios, i.e., testosterone (T), epitestosterone (E), androsterone (A), etiocholanolone (Etio), 5 α -androstane-3 α ,17 β -diol (5 α Adiol), 5 β -androstane-3 α ,17 β -diol (5 β -ADiol), T/E, A/T, A/Etio, 5 α Adiol/5 β Adiol and 5 α Adiol/E, while testosterone, androstenedione (A4) and T/A4 ratios were determined both in serum and DBS. Results While NMC phases only impacted few parameters, COC intake induced significant changes in urine steroid profile with significant decrease in E coupled to higher T/E and 5 α Adiol/E ratio. COC also modified blood ABP steroid profiles, as its administration influenced, irrespective of the inactive/active phase, not only A4 levels but also T/A4 ratio in both serum and DBS. Although steroids demonstrated a good agreement between these two matrices with a stable T/A4 ratios over menstrual phases, all DBS values were significantly lower compared with serum ( p < 0.01). Discussion In conclusion, these results underscored the necessity of considering COC use within the context of longitudinal monitoring as well as the potential impact of physical training. In addition, findings highlighted the potential interest of DBS samples, taking into account intra-individual variations, essential in an ABP approach.
Authors
- Caroline Teulier (ORCID: https://orcid.org/0000-0003-4400-783X)
- Virgile Amiot
- Magnus Ericsson (ORCID: https://orcid.org/0000-0002-4123-3084)
- Emmanuelle Duron (ORCID: https://orcid.org/0000-0001-6680-3613)
- Katia Collomp (ORCID: https://orcid.org/0000-0001-6004-7052)
- Carole Castanier (ORCID: https://orcid.org/0000-0002-8808-9366)
- Corinne Buisson (ORCID: https://orcid.org/0000-0001-5401-8431)
- Cynthia Mongongu (ORCID: https://orcid.org/0000-0003-3532-7065)
- Agnès Olivier (ORCID: https://orcid.org/0000-0003-1548-4397)
- Eric Favory
Institutions
- Université d'Orléans (FR)
- Inserm (FR)
- Université Paris-Saclay (FR)
- Complexité, Innovation et Activités Motrices et Sportives (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Centre hospitalier universitaire d'Orléans (FR)
- Institut Français du Cheval et de l'Équitation (FR)
- Hôpital Paul-Brousse (FR)
- Laboratoire AntiDopage Français (FR)
Publication Details
- Journal
- Frontiers in Sports and Active Living
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fspor.2026.1906734
- Primary Topic
- Doping in Sports
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- World Anti-Doping Agency
- Agence Française de Lutte contre le Dopage